Literature DB >> 20631071

Monitoring of natural killer cell immunotherapy using noninvasive imaging modalities.

Priyanka Jha1, Daniel Golovko, Sukhmine Bains, Daniel Hostetter, Reinhard Meier, Michael F Wendland, Heike E Daldrup-Link.   

Abstract

Cancer immunotherapies can be guided by cellular imaging techniques, which can identify the presence or absence of immune cell accumulation in the tumor tissue in vivo and in real time. This review summarizes various new and evolving imaging techniques employed for tracking and monitoring of adoptive natural killer cell immunotherapies.

Entities:  

Mesh:

Year:  2010        PMID: 20631071      PMCID: PMC2917347          DOI: 10.1158/0008-5472.CAN-09-3774

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Monitoring of a new approach of immunotherapy with allogenic (111)In-labelled NK cells in patients with renal cell carcinoma.

Authors:  Birgit Meller; Christoph Frohn; Jörg-Matthias Brand; Isabel Lauer; Lutz F Schelper; Katharina von Hof; Holger Kirchner; Eckart Richter; Manfred Baehre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-19       Impact factor: 9.236

2.  Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?

Authors:  Jeffrey S Miller
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

3.  [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.

Authors:  Coralie Chaise; Emmanuel Itti; Yolande Petegnief; Evelyne Wirquin; Christiane Copie-Bergman; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue; Michel Meignan; Jean-Noël Talbot; Valérie Molinier-Frenkel
Journal:  Cancer Immunol Immunother       Date:  2006-12-14       Impact factor: 6.968

Review 4.  Cell tracking with optical imaging.

Authors:  Elizabeth J Sutton; Tobias D Henning; Bernd J Pichler; Christoph Bremer; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2008-05-28       Impact factor: 5.315

5.  Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.

Authors:  Yong Taik Lim; Mi Young Cho; Young-Woock Noh; Jin Woong Chung; Bong Hyun Chung
Journal:  Nanotechnology       Date:  2009-10-29       Impact factor: 3.874

6.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.

Authors:  Joseph A Frank; Brad R Miller; Ali S Arbab; Holly A Zywicke; E Kay Jordan; Bobbi K Lewis; L Henry Bryant; Jeff W M Bulte
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

7.  Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors.

Authors:  R J Melder; A L Brownell; T M Shoup; G L Brownell; R K Jain
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

Review 8.  Molecular imaging of breast cancer.

Authors:  T H Oude Munnink; W B Nagengast; A H Brouwers; C P Schröder; G A Hospers; M N Lub-de Hooge; E van der Wall; P J van Diest; E G E de Vries
Journal:  Breast       Date:  2009-10       Impact factor: 4.380

9.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.

Authors:  Matthias Edinger; Yu-An Cao; Michael R Verneris; Michael H Bachmann; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Detection of postoperative granulation tissue with an ICG-enhanced integrated OI-/X-ray System.

Authors:  Reinhard Meier; Sophie Boddington; Christian Krug; Frank L Acosta; Daniel Thullier; Tobias D Henning; Elizabeth J Sutton; Sidhartha Tavri; Jeffrey C Lotz; Heike E Daldrup-Link
Journal:  J Transl Med       Date:  2008-11-27       Impact factor: 5.531

View more
  17 in total

1.  Development and optimization of near-IR contrast agents for immune cell tracking.

Authors:  Pratixa P Joshi; Soon Joon Yoon; Yun-Sheng Chen; Stanislav Emelianov; Konstantin V Sokolov
Journal:  Biomed Opt Express       Date:  2013-10-24       Impact factor: 3.732

Review 2.  Noninvasive cell-tracking methods.

Authors:  Moritz F Kircher; Sanjiv S Gambhir; Jan Grimm
Journal:  Nat Rev Clin Oncol       Date:  2011-09-27       Impact factor: 66.675

3.  Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.

Authors:  Bridget A Kennis; Keith A Michel; William B Brugmann; Alvaro Laureano; Rong-Hua Tao; Srinivas S Somanchi; Samuel A Einstein; Javiera B Bravo-Alegria; Shinji Maegawa; Andrew Wahba; Simin Kiany; Nancy Gordon; Lucia Silla; Dawid Schellingerhout; Soumen Khatua; Wafik Zaky; David Sandberg; Laurence Cooper; Dean A Lee; James A Bankson; Vidya Gopalakrishnan
Journal:  J Neurooncol       Date:  2019-02-20       Impact factor: 4.130

4.  Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.

Authors:  Kangan Li; Andrew C Gordon; Linfeng Zheng; Weiguo Li; Yang Guo; Jing Sun; Guixiang Zhang; Guohong Han; Andrew C Larson; Zhuoli Zhang
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

5.  Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine-19 MRI.

Authors:  Lawrence M Lechuga; Matthew H Forsberg; Kirsti L Walker; Kai D Ludwig; Christian M Capitini; Sean B Fain
Journal:  NMR Biomed       Date:  2021-08-18       Impact factor: 4.044

6.  MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model.

Authors:  Alexander Y Sheu; Zhuoli Zhang; Reed A Omary; Andrew C Larson
Journal:  Invest Radiol       Date:  2013-06       Impact factor: 6.016

7.  (19)F-MRI for monitoring human NK cells in vivo.

Authors:  Myriam N Bouchlaka; Kai D Ludwig; Jeremy W Gordon; Matthew P Kutz; Bryan P Bednarz; Sean B Fain; Christian M Capitini
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 8.  NK cell-based immunotherapy for malignant diseases.

Authors:  Min Cheng; Yongyan Chen; Weihua Xiao; Rui Sun; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-04-22       Impact factor: 11.530

9.  Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes.

Authors:  Travis M Shaffer; Matthew A Wall; Stefan Harmsen; Valerie A Longo; Charles Michael Drain; Moritz F Kircher; Jan Grimm
Journal:  Nano Lett       Date:  2015-01-15       Impact factor: 11.189

Review 10.  Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications.

Authors:  Yueh-Hsia Luo; Louis W Chang; Pinpin Lin
Journal:  Biomed Res Int       Date:  2015-06-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.